Connect with us!
Like us!
Follow us!

Culture marked by the
spirit of innovation and
agile entrepreneurship
in the unwavering pursuit
of excellence.


1999

Started as India’s first independent product development company

2009

Commissioned oral solids manufacturing facility in Ambernath, India

2010

First ANDA filing

2013

First US FDA facility inspection

2014

First own ANDA approval

Established Advagen Pharma in the US

2019

Acquired 15 ANDAs

Sixth successful US FDA inspection

$100 million growth capital commitment by General Atlantic

Acquired Impopharma Canada Ltd and established Rubicon Research Canada Ltd for nasal and pulmonary research

2020

Launch of Rubicon Consumer Healthcare

Launch of Rubicon Academy